Seminar Series

This interdisciplinary seminar series addresses cutting-edge clinical, translational, and basic research topics in cancer and is a focal point of the educational and inter-programmatic activities of the Cancer Center.

As of Friday, March 20, 2020, these weekly seminars are currently being held virtually via Zoom due to institutional health restrictions. CME credit will still be available for those who attend seminars live via Zoom. If you are unfamiliar with Zoom, click here to view instructions and support topics. Contact Kelsey Kirsch ( for more information.

To watch the seminar in real-time and ask questions via chat, click the button below at 12p each Friday.  Presentations are recorded but will not be available for later viewing.

Join the Zoom Meeting 

Upcoming Seminar Series Presentations

4/16/2021 Mikhail Shapiro, PhD
Professor of Chemical Engineering
Investigator, Heritage Medical Research Institute
California Institute of Technology

"Talking to Cells: Biomolecular Engineering for Non-Invasive Imaging and Control of Cellular Function"

Presented by the Cancer Imaging Program
4/23/2021 Jeffrey Myers, MD, PhD, FACS
Chair, Department of Head and Neck Surgery
Alando J. Ballantyne Distinguished Chair of Head and Neck Surgery
Deputy Chair for Academic Programs
Director of Research, Department of Head and Neck Surgery
Director of Translational Research, Division of Surgery
MD Anderson Cancer Center

"Gain of Function Mutant TP53's Impact on the Head and Neck Squamous Cell Carcinoma Tumor Micro-Environment"

Presented by the Molecular Oncology Program

Karen Knudsen, MBA, PhD
Executive Vice President, Oncology Services, Jefferson Health
Enterprise Director, NCI-Designated Sidney Kimmel Cancer Center at Jefferson
Thomas Jefferson University
Chair & Hilary Koprowski Endowed Professor, Department of Cancer Biology

"Novel Strategies for Targeting Advanced Prostate Cancer"

Special Presentation: Olof Pearson Lecture

5/7/2021 Christina Curtis, PhD, MSc
Associate Professor of Medicine and Genetics
Stanford University School of Medicine
Co-Director, Molecular Tumor Board
Stanford Cancer Institute

Presented by the Cancer Data Sciences Group